Physician profile
Kyle B Vincent
NPI 1093964736
$5,395.22
in general payments reported to CMS, 2019-2025
13 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $19.16 · 2021: $12.50 · 2022: $3,269 · 2024: $262 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314 · Travel and Lodging: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.67 |
| Travel and Lodging | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,278.75 | 2019-2025 | |
| Davol INC. | $504.62 | 2019-2022 | |
| Boston Scientific Corporation | $130.00 | 2024 | Spyglass Discover |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2024 | Enhertu |
| Medtronic, INC. | $105.67 | 2025 | Ligasure |
| Conmed Corporation | $100.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $55.90 | 2025 | |
| Allergan, INC. | $24.54 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.96 | 2025 | Myrisk |
| Shire North American Group INC | $17.67 | 2019 | |
| Ethicon US, LLC | $14.27 | 2019 | |
| Reprise Biomedical, INC. | $12.57 | 2025 | Miro3d |
| Thd America, INC. | $7.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Vincent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.